Labiotech.eu’s Post

🧬 Exciting news from the world of stem cell research! A recent study demonstrates how induced pluripotent stem cells (iPSCs) culture can be efficiently scaled up using microcarriers, achieving a higher expansion rate compared to traditional aggregate methods. 🌟 This innovative approach opens up new possibilities for advancing research and application in regenerative medicine, drug discovery, and beyond. 🚀 Interested in elevating your iPSCs culture to the next level? Get in touch with Smart MCs for cell-type specific and customised microcarrier solutions designed to optimize your research. 🌐 Let's innovate together for a healthier future! 💡 #StemCellResearch #iPSCs #RegenerativeMedicine #Biotechnology #Innovation #SmartMCs #ScienceandTechnology Read More: https://lnkd.in/gChqbDfE

The stem cell therapy market for osteoarthritis is rapidly evolving, with several key players driving innovation and growth. Here's a brief look at the leaders shaping this promising field: 🔬 Medipost - Pioneering advanced stem cell treatments with a focus on regenerative medicine, Medipost is enhancing osteoarthritis management through cutting-edge technologies. #Medipost #StemCellTherapy 🔬 Nature Cell - Specializing in cellular therapies, Nature Cell is making strides in developing effective stem cell solutions for osteoarthritis, aiming to improve patient outcomes. #NatureCell #Osteoarthritis 🔬 Theracell Advanced Biotechnology - With a robust portfolio of regenerative therapies, Theracell is at the forefront of stem cell innovation, offering novel treatments for osteoarthritis. #Theracell #AdvancedBiotechnology 🔬 Takeda (TiGenix) - Through its acquisition of TiGenix, Takeda is leveraging advanced stem cell research to advance osteoarthritis therapies, focusing on transformative solutions for patients. #Takeda #TiGenix #HealthcareInnovation #RegenerativeMedicine #Biotech #MedicalResearch #ClinicalTrials #PatientCare #Pharma #Biotechnology #HealthTech #FutureOfMedicine #StemCellTherapy #OsteoarthritisTreatment #RegenerativeMedicine #StemCellResearch #Osteoarthritis #CellularTherapy #MedicalInnovation #Healthcare #Biotech #Pharmaceuticals Read Report @ https://lnkd.in/gzKkt8Zs

The stem cell therapy market is well-established and has evolved to focus on adult stem cells to treat a variety of medical indications, with active and completed regenerative programs having garnered significant investment from the biotechnology community. In contrast, the exosome therapy market is a newer and rapidly growing sector that relies on harnessing nano-sized vesicles for regenerative purposes, showing promise in diverse medical indications and attracting growing attention from investors and biotech companies. #PranaX #Exosomes #Stemcells #Biotech #Health #Wellness #Medicine

👁️ 𝐅𝐢𝐫𝐬𝐭 𝐬𝐭𝐞𝐦 𝐜𝐞𝐥𝐥 𝐭𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭 𝐫𝐞𝐬𝐭𝐨𝐫𝐞𝐬 𝐯𝐢𝐬𝐢𝐨𝐧 𝐢𝐧 𝐩𝐞𝐨𝐩𝐥𝐞 The study published in The Lancet described the case of four individuals with severely impaired vision due to limbal stem cell deficiency (LSCD) who received corneal transplants derived from reprogrammed stem cells.  The treatment developed at Osaka University in Japan used induced pluripotent stem (iPS) cells that were reprogrammed into corneal epithelial cells and grafted onto the damaged corneas. Two years post-treatment, patients have not experienced severe side effects or immune rejection. Very exiting! 𝐓𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐥𝐨𝐨𝐤𝐬 𝐛𝐫𝐢𝐠𝐡𝐭. #trials #ipscs #biotech #pharma #drjojo Source in the comments section ---------- Hi! I am Joanna, and my friends call me Dr Jojo 🌸 𝐈 𝐡𝐞𝐥𝐩 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬 𝐚𝐧𝐝 𝐞𝐧𝐭𝐫𝐞𝐩𝐫𝐞𝐧𝐞𝐮𝐫𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐡𝐞𝐢𝐫 𝐯𝐚𝐥𝐮𝐞 𝐚𝐧𝐝 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 ♻️ Share this if you find it interesting 🔔 Follow for insights you won't want to miss 📩 DM me to increase your visibility, grow your business, and generate leads

Using iPSCs as starting material for advanced therapies

#ArticleoftheWeek published by #sciencedirect Organoids are transforming biomedical research: In a new study by Elisa Heinzelmann et al., induced pluripotent stem cell (iPSC) organoids are highly flexible but require a significant time investment to assemble. Patient-derived organoids are faster to create but show variability due to patient-specific traits. Both offer significant potential for drug discovery and personalized medicine. Automation is fast-tracking organoid technology toward clinical use— the next big medical breakthrough might just come from a lab dish! https://lnkd.in/e4bJC94B 🎉 Congratulations to: Elisa Heinzelmann, PhD, Francesco Piraino, PhD, Mariana Costa, Aline Roch, Maxim Norkin, Virginie Garnier, Krisztian Homicsko, Nathalie Brandenberg #Organoids #StemCells #Biotech #PersonalizedMedicine #DrugDiscovery #Incubator

🚀 Exciting Developments in the Mesenchymal Stem Cells (MSC) Market! The MSC market is witnessing remarkable growth, increasing from $3.00 billion in 2023 to $3.38 billion in 2024, with a 12.5% CAGR. Projections show the market reaching $5.45 billion by 2028 with a 12.7% CAGR. Key drivers of this growth include: 🌟 A paradigm shift towards regenerative medicine 🤝 Collaborative research efforts 📣 Increased public awareness and patient advocacy 🌐 International collaboration and standardization Looking ahead, the future of the MSC market is promising, driven by: 🧬 Advances in genetic engineering and personalized medicine 🤖 Integration of AI and data analytics 🧩 Innovations in biomaterials and 3D bioprinting 🧪 Development of microfluidic devices and organ-on-a-chip models ⚙️ Adoption of next-generation manufacturing technologies Additionally, major trends such as bioprinting, gene editing, expanded clinical applications, combination therapies, and the study of MSC-derived extracellular vesicles are gaining traction. As the largest market, North America is leading the way, while Asia-Pacific is the fastest-growing region. With ongoing advancements and strategic investments, the MSC market is poised for significant growth. 🔗 For a detailed report, visit: Mesenchymal Stem Cells Market Report 2024 https://lnkd.in/gcBzFgnq

The global stem cells market is expected to grow at a robust rate of 9-12% for Forecasts 2023 to 2028. To learn more: https://lnkd.in/dJBKrb-h 🚀 This growth is driven by several factors: 🔹 Increasing prevalence of chronic diseases 🏥 🔹 Surge in research activities and favorable government support 🧬 🔹 Expanding clinical applications in regenerative medicine 🌿 🔹 Technological advancements in stem cell therapies 🔬 #StemCells #RegenerativeMedicine #Biotechnology #HealthTech #MedicalDevices #FutureOfHealthcare #Genomics #BioPharma